Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial

著者: Bradley J. Monk, Nicoletta Colombo, Amit M. Oza, Keiichi Fujiwara, Michael J. Birrer, Leslie M. Randall, Elena Poddubskaya, Giovanni Scambia, Yaroslav Shparyk, Myong Cheol Lim, Snehalkumar M Bhoola, Joohyuk Sohn, Kan Yonemori, Ross Stewart, Xiaoxi Zhang, Julia Perkins Smith, Carlos Linn, Jonathan A. Ledermann - The Lancet 2021 被引用: 284